HTG EdgeSeq PATH Assay

HTG Molecular Diagnostics plans to launch the HTG EdgeSeq PATH Assay for research use only by the end of the second quarter. The assay has been designed for retrospective gene expression profiling to complement traditional immunohistochemistry (IHC) testing. The test assesses mRNA expression of large numbers of biomarkers when formalin-fixed, paraffin-embedded sample availability is limited, the company said. It is designed to detect up to 470 mRNA targets, typically assessed by IHC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.